Prestige Consumer Q1 revenue $265.7M (+6.5%), adj. EPS $0.98; raises FY outlook to $1.29-1.315B

Prestige Consumer Healthcare Inc.

Q1 revenue $265.7M (+6.5% YoY); organic sales growth 3.2% exceeded expectations.
GAAP diluted EPS $0.61; adjusted diluted EPS $0.98 vs $0.95 prior year.
Closed Breathe Right acquisition (June) and LaCorium (July); added $6M revenue in Q1.
Raised FY2027 outlook: revenue $1,290-$1,315M, adj. EPS $4.55-$4.65 (from $4.42-$4.51).
Issued $400M 6.25% senior notes due 2034, extending nearest maturity to 2031.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.